@Article{Yaman2019,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="23",
number="1",
year="2019",
title="Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation",
abstract="In the pediatric population, hematopoietic stem cell transplantation (HSCT) is used to treat a wide variety of diseases, both malignant and nonmalignant. For many of these diseases, HSCT is a well-established treatment. Acute graft-versus-host disease (GVHD) continues to be a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Graft versus host disease is a common complication of allo-SCT which is induced by donor T cell recognition of recipient alloantigens. The occurrence of autologous GVHD suggests that inappropriate recognition of host self-antigens may occur. GVHD in patients who received autologous HSCT is extremely rare compared to patients who received allogeneic HSCT. We present the case of a 4-year-old girl with metastatic neuroblastoma who spontaneously developed autologous GVHD after autologous HSCT.",
author="Yaman, Yöntem
and Baysoy, Gökhan
and Keleşoğlu, Emre
and Özdilli, Kürşat
and Çakır, Aslı
and Genç, Dildar Bahar
and Elli, Murat
and Anak, Sema",
pages="59--62",
doi="10.5114/wo.2019.83815",
url="http://dx.doi.org/10.5114/wo.2019.83815"
}